The trazodone metabolite meta-chlorophenylpiperazine can cause false-positive urine amphetamine immunoassay results

Journal of Analytical Toxicology

Volumn 35, Issue 6, 2011, Pages 364-368

  Baron, Jason M ^a   Griggs, David A ^a   Nixon, Andrea L ^a   Long, William H ^a   Flood, James G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; CREATININE; METHAMPHETAMINE; TRAZODONE;

ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; DRUG SCREENING; DRUG URINE LEVEL; FALSE POSITIVE RESULT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOREACTIVITY; MASS FRAGMENTOGRAPHY; URINALYSIS;

EID: 79960339172     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/anatox/35.6.364     Document Type: Article

References (14)

1. K.E. Moeller, K.C. Lee, and J.C. Kissack. Urine drug screening: Practical guide for clinicians. Mayo Clin. Proc. 83: 66-76 (2008).
2. M.R. Pincus and N.Z. Abraham, Jr. Toxicology and therapeutic drug monitoring. In Henry's Clinical Diagnosis and Management by Laboratory Methods, R.A. McPherson, M.R. Pincus, and J.B. Henry, Eds. Saunders Elsevier, Philadelphia, PA, 2007, pp 197-325.
3. P.R. Puopolo, S.A.Volpicelli, D.M. Johnson, and J.G. Flood. Emergency toxicology testing (detection, confirmation, and quantification) of basic drugs in serum by liquid chromatography with photodiode array detection. Clin. Chem. 37: 2124-2130 (1991).
4. B.K. Logan, A.G. Costantino, E.F. Rieders, and D. Sanders. Trazodone, meta-chlorophenylpiperazine (an hallucinogenic drug and trazodone metabolite), and the hallucinogen trifluoromethylphenylpiperazine cross-react with the EMIT II ecstasy immunoassay in urine. J. Anal. Toxicol. 34: 587-589 (2010).
5. S. Rotzinger, M. Bourin, Y. Akimoto, R.T. Coutts, and G.B. Baker. Metabolism of some "second" - and "fourth" -generation antidepressants: iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine. Cell Mol. Neurobiol. 19: 427-442 (1999).
6. H.H. Maurer, T. Kraemer, D. Springer, and R.F. Staack. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. Ther. Drug Monit. 26: 127-131 (2004).
7. J. Kovaleva, E. Devuyst, P. De Paepe, and A. Verstraete. Acute chlorophenylpiperazine overdose: a case report and review of the literature. Ther. Drug Monit. 30: 394-398 (2008).
8. Roche Diagnostics. Amphetamines II, http://mylabonline.com (accessed December 2010, log in required).
9. N.T. Lu and B.G. Taylor. Drug screening and confirmation by GC-MS: comparison of EMIT II and online KIMS against 10 drugs between US and England aboratories. Forensic Sci. Int. 157: 106-116 (2006).
10. P.R. Puopolo, M.E. Pothier, S.A.Volpicelli, and J.G. Flood. Single procedure for detection, confirmation, and quantification of benzodiazepines in serum by liquid chromatography with photodiode-array detection. Clin. Chem. 37: 701-706 (1991).
11. Rochester test catalog: 2011 online test catalog. Mayo medical laboratories, http://www.mayomedicallaboratories.com/test-catalog/ (January 2011).
12. R.J. Roberge, J.R. Luellen, and S. Reed. False-positive amphetamine screen following a trazodone overdose. J. Toxicol. Clin. Toxicol. 39: 181-182 (2001).
13. R.J. Craig. Urine screening for drugs and trazodone. Br. J. Psychiatry 169: 669-670 (1996).
14. J.M. Grohol. Top 25 psychiatric prescriptions for 2009, http://psychcentral.com/lib/2010/top-25-psychiatric-prescriptions-for-2009/ (accessed January 2011).